Cure Alzheimer’s Fund

• Founded

  1 Jan 2004

Sources: ror.org

• Sex differences in locus coeruleus structure and function across the adult lifespan: effects of APOE, Alzheimer’s disease pathology, and estrogen levels

  6 Oct 2026

• World Trade Center neurotoxicant exposure severity is associated with cortical thinning and regional brain atrophy: a neuroimaging study of general responders at midlife

  R01AG084699, R01AG093879, R01AG093281, 1 Oct 2026

• NAD+ augmentation in brain aging: hype, hope, or emerging reality?

  282952, 22 Sept 2026

• Epitope placement tunes CSF tau biomarkers: Comparison of P-tau217 and BD-tau designs

  22 Sept 2026

• Sequalae and reversal of age-dependent alterations in mitochondrial dynamics via autophagy enhancement in reprogrammed human neurons

  23 Aug 2026

• Senescent microglia with shortened telomeres secrete soluble DLK1 to induce aging-associated hypomyelination and neuronal dysfunction

  11 Aug 2026

• Astrocyte reactivity modifies the effects of locus coeruleus norepinephrine-related dysfunction on tau and its impact on cognition

  1 Aug 2026

• CSF fibrinogen predicts longitudinal Tau accumulation in cognitively unimpaired older adults

  1 Aug 2026

• A plasma-based protein signature combining NPTXR, ACHE, and p-tau217 predicts progression to symptomatic Alzheimer's disease

  1 Aug 2026

• A combined artificial intelligence-wet lab approach identifies a pivotal role of the NAD+-mitophagy axis on aging and neurodegeneration

  #282952, #284930, 1 Aug 2026

• Comprehensive cross-sectional and longitudinal comparison of sixteen markers of biological aging from the Berlin Aging Study II

  CIR-CUITS, 27 Mar 2026

• Socio-economic influences from egg to exit: Emerging biology

  20 Mar 2026

• Liver exerkine reverses aging- and Alzheimer's-related memory loss via vasculature

  18 Feb 2026

• Frailty and prognosis of biomarker-confirmed Alzheimer's disease: a Swedish, register-based, retrospective cohort study

  17 Dec 2025

• Sea urchin bioactive compounds: emerging interventions for age-related diseases

  282952, 28493, 29 Nov 2025

• Adapting health, economic and social policies to address population aging in China

  282952, 284930, 31 Oct 2025

• Synaptic dysfunction and glial activation markers throughout aging and early neurodegeneration: a longitudinal CSF biomarker-based study

  17 Oct 2025

• Lifespan Trajectories of Asymmetry in White Matter Tracts

  200775, 29 Sept 2025

• Hypertension-Induced Neurovascular and Cognitive Dysfunction at Single-Cell Resolution

  243348, 19 Sept 2025

• Emerging strategies, applications and challenges of targeting NAD+ in the clinic

  282952, 284930, 9 Sept 2025

Sources: api.crossref.org, pubmed.ncbi.nlm.nih.gov

• A Harmonized Visual Reading Framework for Tau PET Staging in Alzheimer Disease

  Grants or research support, 21 Sept 2026

Sources: pubmed.ncbi.nlm.nih.gov

• The purinergic signaling in Alzheimer's disease: possible use of a shed form of the P2X7 receptor (sP2X7R) as a biomarker of early dementia

  AAIC 2025 abstract, 24 Dec 2025